Bell’s palsy’s viral pathogenicity and the use of botulinum toxin type A as treatment

Abstract

Bell’s palsy is the common name for the inflammation of the cranial nerve VII. The peculiar geniculate ganglion inflammation is idiopathic and causes hemifacial paralysis. Patients who suffer from this paralysis may have their symptoms dissipate between 3 weeks and 3 months. For certain patients whose facial paralysis persist, botulinum toxin type- A might be an efficient treatment. Depending on the severity of the muscular palsy, different treatments can be offered including surgery, steroid, and anti-viral treatment as well as Botox. This review article’s purpose is to dive into the possible correlation of viral pathogens with the activation of the facial nerve inflammation, and how patients with Bell’s palsy can benefit from Botox type-A as treatment.

Keywords

• bell paralizi
• botulinum toksin tip a
• botoks
• fasiyal sinir
• kas felci
• bell’s palsy
• botulinum toxin type a
• botox
• facial nerve
• muscular paralysis